Onconova Therapeutics' Unattributed Round

Onconova Therapeutics raised a round of funding on March 09, 2009. Investors include Ben Franklin Technology Partners of Central & Northern PA.

Onconova Therapeutics, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drug candidates to treat cancer. The company¬ís clinical-stage product candidate…

Articles about Onconova Therapeutics' Unattributed Round: